Ackman: No Plans to Sell Any Valeant `Crown Jewel' Assets -CNBC
02 Maio 2016 - 2:34PM
Dow Jones News
Activist investor William Ackman on Monday said there will be no
"crown jewel" asset sales at Valeant Pharmaceuticals International
Inc. (VRX), but that the company would consider the sale on non
core assets.
Mr. Ackman, who holds a board seat at the drug company, also
told CNBC in an interview that Valeant's board "absolutely" would
take up the issue of potential roll backs to some of the company's
drug prices. The Valeant board, he said, would take up the issue
"promptly."
The Pershing Square Holdings Ltd. chief executive also said that
a renaming of the company is a possibility.
CNBC website: www.cnbc.com
Write to nymonitoring@dowjones.com
(END) Dow Jones Newswires
May 02, 2016 13:19 ET (17:19 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Pershing Square (EU:PSH)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Pershing Square (EU:PSH)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Notícias em tempo-real sobre Pershing Square Holdings Ltd da Euronext bolsa de valores: 0 artigos recentes
Mais Notícias de Pershing